TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
Seong Su Kang(Emory University), Keqiang Ye(Shenzhen University Health Science Center), Yi Sun(Institute of Microbiology), Fredric P. Manfredsson(Barrow Neurological Institute), Xia Liu(Northwestern University), Zhentao Zhang(Wuhan University), Matthew J. Benskey(Michigan State University), Xuebing Cao(Union Hospital), Jun Xu(Heilongjiang University of Science and Technology)
Cited by 133
Related Papers
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management
|Orphanet Journal of Rare Diseases|2014|315
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
|Nature Communications|2015|280
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
|Brain|2020|167
Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death
|Proceedings of the National Academy of Sciences|2007|161